Back to the search results

Paracelsus-Elena-Klinik

Paracelsus-Elena-Klinik
Paracelsus-Elena-Klinik

Klinikstraße 16
34128 Kassel

Phone: 0561-6009-0
Fax: 0561-6009-125
Mail: ed.dkp.lessak@ofni

  • Number of beds: 120
  • Number of specialist departments: 1
  • Number of inpatient cases: 2.261
  • Number of outpatient cases: 444
  • Hospital owners: Paracelsus-Kliniken Deutschland GmbH&Co. KGaA, Osnabrück
  • Type of provider: privat
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of the minimum quantity agreement
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
14 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
13 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
13 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? No
  • No care for children and young people
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • elektronisches Medikamentenbestellsystem, elektronische Patientenakte
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Frau Prof. Dr. med. Brit Mollenhauer: Studentenkurse Universität Göttingen Frau PD Dr. med. Friederike Sixel-Döring: Studentenkurre Universität Marburg, Dr. med. Maria-Lucia Muntean Studentenkurse Göttingen

Explanation

3 Studien (Thema Parkinson),

Explanation

Parkinson-Zentrum Universität Göttingen-Kassel, Kooperation zur Tiefen Hirnstimulation mit Universität Göttingen, ExpoBiome Projekt mit Universität Luxemburg und Charite Berlin, diverse Michael J. Fox-Projekte, Zusammenarbeit mit der Universität Göttingen

Explanation

Frau UnivProf. Dr. med. Claudia Trenkwalder: 1 Frau Prof. Dr. med. Brit Mollenhauer: 2

Explanation

Frau UnivProf. Dr. med. Claudia Trenkwalder Kurs: Schlafmedizin Universität Göttingen, Frau Prof. Dr. med. Brit Mollenhauer: Stiftungsprofessur Universität Göttingen, Frau PD Dr. med. Friederike Sixel-Döring: Lehrauftrag Universität Marburg

Training in other healing professions
Comment

Praktikumsplätze für den Fachpraktischen Ausbildungseinsatz der Fachschulen / Studiengänge werden vorgehalten

Comment

Praktikumsplätze für den Fachpraktischen Ausbildungseinsatz der Fachschulen / Studiengänge werden vorgehalten

Jutta Dörr

Patientenfürsprecherin

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-0
Mail: ed.dkp@rreod.attuj.txe

Ursula Reuß

Qualitätsbeauftragte

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-104
Mail: ed.dkp@ssuer.alusru

Ursula Reuss

Qualitätsbeauftragte

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-104
Mail: ed.dkp@ssuer.alusru

UnivProf. Dr. med. Brit Mollenhauer

Ärztliche Leiterin

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-200
Mail: ed.dkp.lessak@tairaterkestzrafehc

UnivProf. Dr. med. Brit Mollenhauer

Ärztliche Leiterin

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-200
Mail: ed.dkp.lessak@tairaterkestzrafehc

Dr. med. Jens Ebentheuer

Oberarzt

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-159
Mail: ed.dkp@reuehtnebe.snej

Soziale Arbeit B.A. Elisabeth Lang

Sozialdienst

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-255
Mail: ed.dkp@gnal.htebasile

Klinikstraße 16
34128 Kassel

Phone: 0561-6009-0
Fax: 0561-6009-125
Mail: ed.dkp.lessak@ofni

Pflegemanager B.A. Werner Murza

Kompetenznetzwerk Pflege- und Funktionsdienst

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-115
Mail: ed.dkp@azrum.renrew

David Behnisch

Klinikmanager

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-115
Mail: ed.dkp@hcsinheb.divad

David Behnisch

Klinikmanager

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-115
Mail: ed.dkp@hcsinheb.divad

David Behnisch

Klinikmanager

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-115
Mail: ed.dkp@hcsinheb.divad

David Behnisch

Klinikmanager

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-115
Mail: ed.dkp@hcsinheb.divad

UnivProf. Dr. med. Brit Mollenhauer

Ärztliche Leiterin

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-200
Mail: ed.dkp.lessak@tairaterkestzrafehc

UnivProf. Dr. med. Brit Mollenhauer

Ärztliche Leiterin

Klinikstraße 16
34128 Kassel

Phone: 0561 -6009-200
Mail: ed.dkp.lessak@tairaterkestzrafehc

IK: 260620146

Location number: 771912000

Old location number: 771912000